Home

Aurobindo Pharma Ltd 52 Week Low

Image

Aurobindo Pharma Ltd

NSE: AUROPHARMA

YEARLOW

₹ 985

Last updated on: Mar 06, 2025

Key Highlights

  • The 52 Week Low of Aurobindo Pharma Ltd is ₹ 985 as of 06 Mar 25 .

Company Fundamentals for Aurobindo Pharma Ltd

Market Price of Aurobindo Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Aurobindo Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
06 Mar 20251113.8
05 Mar 20251092.3
04 Mar 20251051.75
03 Mar 20251061.3
28 Feb 20251057.95
27 Feb 20251079.85
25 Feb 20251081.4
24 Feb 20251101.5
21 Feb 20251115.45
20 Feb 20251120.85

Asset Value vs Market Value of Aurobindo Pharma Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Historical Revenue of Aurobindo Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Aurobindo Pharma Ltd

No data available

* All values are in crore

Aurobindo Pharma Ltd News Hub

Aurobindo Pharma tumbles after US FDA issues warning letter to Telangana unit

In May 2024, the United States Food and Drug Administration (US FDA) had conducted an inspection at

Read more

16 Aug 24

Eugia Pharma Specialities receives USFDA warning for Unit III

Aurobindo Pharma announced that the USFDA has issued a warning letter for Unit-III of Eugia Pharma S

Read more

16 Aug 24

Aurobindo Pharma consolidated net profit rises 61.05% in the June 2024 quarter

Net profit of Aurobindo Pharma rose 61.05% to Rs 919.22 crore in the quarter ended June 2024 as agai

Read more

12 Aug 24

Auro Pharma Q3 PAT slides 10% YoY to Rs 846 crore

However, revenue from operations increased 8.53% year on year (YoY) to Rs 7,978.52 crore in the quar

Read more

07 Feb 25

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week Low of Aurobindo Pharma Ltd

Why is it important to track the 52-week low of Aurobindo Pharma Ltd stocks?

Investors should monitor the 52-week low of Aurobindo Pharma Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Aurobindo Pharma Ltd stocks hitting a 52-week low?

Factors leading to Aurobindo Pharma Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Aurobindo Pharma Ltd stocks when they hit a 52-week low?

Buying Aurobindo Pharma Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Aurobindo Pharma Ltd stocks?

Investors should monitor the 52-week low of Aurobindo Pharma Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Aurobindo Pharma Ltd stock at their 52-week low?

An investor can analyze the reasons for the Aurobindo Pharma Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Aurobindo Pharma Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Aurobindo Pharma Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Aurobindo Pharma Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions